In conclusion, in our study, we identified PARM1 as a poor prognostic factor in osteosarcoma by bioinformatics based on the GEO database, and low expression of PARM1 predicted poor prognosis in osteosarcoma patients. Here, PARM1 is linked to osteosarcoma.